https://www.marketscreener.com/quote/stock/NERVGEN-PHARMA-CORP-55763923/news/NervGen-Pharma-Expands-Alzheimer-s-Disease-Scientific-Advisory-Board-35837841/?utm_source=telegram&utm_medium=social&utm_campaign=share